BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16585773)

  • 1. An allele of gyrA prevents Salmonella enterica serovar Typhimurium from using succinate as a carbon source.
    Schmitz GE; Downs DM
    J Bacteriol; 2006 Apr; 188(8):3126-9. PubMed ID: 16585773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation at the "exit gate" of the salmonella gyrase a subunit suppresses a defect in the gyrase B subunit.
    Blanc-Potard AB; Labesse G; Figueroa-Bossi N; Bossi L
    J Bacteriol; 2005 Oct; 187(19):6841-4. PubMed ID: 16166547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of producing DNA gyrase from a synthetic gyrBA operon in Salmonella enterica serovar Typhimurium.
    Pozdeev G; Mogre A; Dorman CJ
    Mol Microbiol; 2021 Jun; 115(6):1410-1429. PubMed ID: 33539568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the dicarboxylate transporter DctA in Corynebacterium glutamicum.
    Youn JW; Jolkver E; Krämer R; Marin K; Wendisch VF
    J Bacteriol; 2009 Sep; 191(17):5480-8. PubMed ID: 19581365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gyrase mutant with low activity disrupts supercoiling at the replication terminus.
    Pang Z; Chen R; Manna D; Higgins NP
    J Bacteriol; 2005 Nov; 187(22):7773-83. PubMed ID: 16267301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of C(4)-dicarboxylate transport systems in Pseudomonas aeruginosa PAO1.
    Valentini M; Storelli N; Lapouge K
    J Bacteriol; 2011 Sep; 193(17):4307-16. PubMed ID: 21725012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA supercoiling differences in bacteria result from disparate DNA gyrase activation by polyamines.
    Duprey A; Groisman EA
    PLoS Genet; 2020 Oct; 16(10):e1009085. PubMed ID: 33125364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress.
    Colgan AM; Quinn HJ; Kary SC; Mitchenall LA; Maxwell A; Cameron ADS; Dorman CJ
    Mol Microbiol; 2018 Mar; 107(6):734-746. PubMed ID: 29352745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a gene encoding a transporter essential for utilization of C4 dicarboxylates in Corynebacterium glutamicum.
    Teramoto H; Shirai T; Inui M; Yukawa H
    Appl Environ Microbiol; 2008 Sep; 74(17):5290-6. PubMed ID: 18586971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth rate toxicity phenotypes and homeostatic supercoil control differentiate Escherichia coli from Salmonella enterica serovar Typhimurium.
    Champion K; Higgins NP
    J Bacteriol; 2007 Aug; 189(16):5839-49. PubMed ID: 17400739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella enterica serovar Typhimurium mutants unable to convert malate to pyruvate and oxaloacetate are avirulent and immunogenic in BALB/c mice.
    Mercado-Lubo R; Leatham MP; Conway T; Cohen PS
    Infect Immun; 2009 Apr; 77(4):1397-405. PubMed ID: 19168732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of orotate as a pyrimidine source by Salmonella typhimurium and Escherichia coli requires the dicarboxylate transport protein encoded by dctA.
    Baker KE; Ditullio KP; Neuhard J; Kelln RA
    J Bacteriol; 1996 Dec; 178(24):7099-105. PubMed ID: 8955389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in yhiT enable utilization of exogenous pyrimidine intermediates in Salmonella enterica serovar Typhimurium.
    Zaharik ML; Lamb SS; Baker KE; Krogan NJ; Neuhard J; Kelln RA
    Microbiology (Reading); 2007 Aug; 153(Pt 8):2472-2482. PubMed ID: 17660412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.
    de Toro M; Rojo-Bezares B; Vinué L; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1945-9. PubMed ID: 20639314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ms2io6A37 modification of tRNA in Salmonella typhimurium regulates growth on citric acid cycle intermediates.
    Persson BC; Olafsson O; Lundgren HK; Hederstedt L; Björk GR
    J Bacteriol; 1998 Jun; 180(12):3144-51. PubMed ID: 9620964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
    Preisler A; Mraheil MA; Heisig P
    J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocks in Tricarboxylic Acid Cycle of Salmonella enterica Cause Global Perturbation of Carbon Storage, Motility, and Host-Pathogen Interaction.
    Noster J; Hansmeier N; Persicke M; Chao TC; Kurre R; Popp J; Liss V; Reuter T; Hensel M
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31826974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
    Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.
    Webber MA; Ricci V; Whitehead R; Patel M; Fookes M; Ivens A; Piddock LJ
    mBio; 2013 Jul; 4(4):. PubMed ID: 23882012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.